Shoutout to Aquilo Partners, L.P. for their generous support of the 2025 Convergence Forum. Your partnership helps make this event a success and we're grateful you're part of this community!
关于我们
What opportunities get created as fields converge? What challenges surface as markets, policies, and investing dynamics shift? What new scientific discoveries are potential game-changers? Convergence exists to explore those questions (and many others), with a high-level audience interested in what's happening in the rapidly-converging worlds of biotech, pharma, healthcare, medical devices, and the Internet. The Convergence Forum fosters real debate and discussion among audiences that are every bit as high-level as the speakers. The programs provide an opportunity for participants to make important new contacts, do business, explore important new directions in research, delve deeply into what it takes to maintain competitive advantage in a fast-changing world, and leave feeling recharged.
- 网站
-
https://convergenceforum.com/
Convergence Forum的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Boston，Massachusetts
- 类型
- 私人持股
- 创立
- 2004
- 领域
- healthcare、life sciences和conference
地点
-
主要
获取路线
75 Arlington Street, 5th Floor
US，Massachusetts，Boston，02116
Convergence Forum员工
-
Scott Kirsner
-
Richard Kivel
Managing Director @ GrayBella Capital | Venture Capital, Innovation
-
Laurie Halloran
Dedicated to sharing best practices & know how in life science to deliver safe & effective products to patients
-
Marian Nakada, Ph.D.
Using BIG for GOOD. Making strategic investments for Johnson & Johnson Innovation - JJDC
动态
-
The full 2025 Convergence Forum agenda is now LIVE ?? This year's lineup features discussions and speakers you won't want to miss.?Find out?who will be talking about what's going on in DC, what the top VCs are thinking about, and the best partnering strategies for 2025. Explore the agenda today! https://lnkd.in/eqtP66Au
-
Pleased to share the new speakers joining the 2025 Convergence Forum lineup this May: Natalie Artzi, Michael C. Chen, Kevin Churchwell, Samarth Kulkarni and Joshua Resnick. Don't miss your chance to be part of the conversation. To learn more, visit https://lnkd.in/ejeUvSBb
-
Thank you to our 2025 sponsor Evotec for their support of the Convergence Forum. To learn more about Convergence Forum, visit https://lnkd.in/ejeUvSBb
-
-
Excited to share that Michael Gilman, CEO of Arrakis Therapeutics; Andy Plump, President, Research & Development at Takeda; Jodie Morrison (She/Her), Acting CEO of Q32 Bio Inc. and Venture Partner at Atlas Venture will be joining us as speakers at the 2025 Convergence Forum. To learn more about the 2-day event in May, visit https://lnkd.in/ejeUvSBb
-
Thank you to our sponsor Worldwide Clinical Trials for their continued support of Convergence Forum. To learn more about the 2025 Convergence Forum visit https://lnkd.in/ejeUvSBb
-
-
Check out Convergence Quantum - a one day program with top industry experts in drug discovery to develop a strategic roadmap for the rapidly advancing role of quantum computing in the field. To learn more visit https://lnkd.in/eJB32egn
Curious about how quantum computing is going to reshape drug discovery? We had a fantastic planning session with leaders in quantum computing and drug discovery for Convergence Quantum 3/11/25, https://lnkd.in/e9CbR9mM, at The Engine Accelerator in Kendall Square. Thanks to Michal Preminger Marian Nakada, Ph.D. and Varun Ramdevan for hosting. Join us, https://lnkd.in/e9CbR9mM, and find out how quantum computing is already starting to reshape drug discovery. Varun Ramdevan José Duca Lesia “Ella” Fejer Andrea de Souza Bruce Church Alyssa Stern Elisha Siddiqui Matekole Stacy Swider Larissa Bifano Madeleine Laitz, PhD Riccardo Sabatini Dario Villani. Convergence Forum
-
-
Great connecting with Convergence Forum Fellows from the Class of 2023 and 2024 today at the offices of Johnson & Johnson Venture Investments JJDC in Cambridge. We started this program in 2023 to support the engagement of promising under-represented researchers and founders from life sciences companies or working on research in the life sciences at the Convergence Forum. Special thanks to Marian Nakada, Ph.D. for jumpstarting the program and Chris Otey who was our first underwriter. It was inspiring to hear about the continuing success of the Fellows who attended today: Alvaro Amorrortu, Andrew Thomson, Ananya Zutshi, Cheri Ackerman. Floris Engelhardt, Phuong Jean Pham, Julia P., Minmin Yen, Ph.D., MPH (she/her), Robert Shaffer, PhD, Shana Wang, Soufiane Aboulhouda. Look forward to seeing you at Convergence Forum 2025 next May and our next class of Fellows.
-
-
Such an invigorating and high energy year for the Convergence Forum on Cape Cod. Thanks to all the speakers and moderators who brought their A game… (not to mention the boat passengers who pitched in to help a captain who ran aground.)
-
-
-
-
-
+5
-
-
Thanks to Chris Otey at Banc of California, Marian Nakada, Ph.D. and Michal Preminger at Johnson & Johnson, Lizabeth Leveille at Merck and Lindsay Androski, CFA at Roivant Social Ventures along with the The Termeer Foundation for bringing together such a fantastic group of Convergence Fellows at the Convergence Forum this year #CVFORUM24 Rachel Salzman, DVM, Alvaro Amorrortu, Roya Khosravi-Far, Ph.D., PLD, Robert Shaffer, PhD, Andrew Thomson, Nele Van Dessel, Phuong Jean Pham, Shana W., Ananya Zutshi, Julia P., Cheri Ackerman, Afreen Allam, Natalie J. Galant, PhD, Kwamane D. Liddell, JD, MHA, BSN, Elizabeth Wood
-